Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion systematic review and meta-analysis of randomised trials

被引:119
作者
Boulouis, Gregoire [1 ,2 ,3 ]
Morotti, Andrea [1 ,2 ]
Goldstein, Joshua N. [1 ,2 ,4 ]
Charidimou, Andreas [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Hemorrhag Stroke Res Grp, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[3] Univ Paris 05, Ctr Hosp St Anne, INSERM UMR 894, Dept Neuroradiol, Paris, France
[4] Harvard Med Sch, Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Boston, MA USA
关键词
CASE-FATALITY; REDUCTION; NITROPRUSSIDE;
D O I
10.1136/jnnp-2016-315346
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Introduction It is unclear whether intensive lowering of blood pressure (BP) at the acute phase of intracerebral haemorrhage (ICH) is beneficial. We performed a metaanalysis of randomised controlled trials (RCTs) to assess whether intensive BP lowering in patients with acute ICH is safe and effective in improving clinical outcomes. Methods We searched PubMed, EMBASE and the Cochrane databases for relevant RCTs and calculated pooled OR for 3-month mortality (safety outcome) and 3-month death or dependency (modified Rankin Scale >= 3; efficacy outcome), in patients with acute ICH randomised to either intensive BP-lowering or standard BP-lowering treatment protocols. We also investigated the association between treatment arm and ICH expansion at 24 hours. Random effects models with DerSimonian-Laird weights were used. Results Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis. The risk of 3-month mortality was similar between patients randomised to intensive BP-lowering treatment and standard BP-lowering treatment (OR: 0.99; 95% CI: 0.82 to 1.20, p = 0.909). Intensive BP-lowering treatment showed a (non-significant) trend for an association with lower 3-month death or dependency risk compared with standard treatment (OR: 0.91; 95% CI: 0.80 to 1.02), p = 0.106). Intensive BP reduction was associated with a trend for lower risk of significant ICH expansion compared with standard treatment (OR: 0.82; 95% CI: 0.68 to 1.00, p = 0.056), especially in larger RCTs. Conclusions For patients with acute ICH similar to those included in RCTs and without contraindication to acute BP treatment, intensive acute BP lowering is safe, but does not seem to provide an incremental clinical benefit in terms of functional outcomes. The effect of intensive BP lowering on significant haematoma expansion at 24 hours warrants further investigation.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 24 条
[1]
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial [J].
Anderson, Craig S. ;
Huang, Yining ;
Wang, Ji Guang ;
Arima, Hisatomi ;
Neal, Bruce ;
Peng, Bin ;
Heeley, Emma ;
Skulina, Christian ;
Parsons, Mark W. ;
Kim, Jong Sung ;
Tao, Qing Ling ;
Li, Yue Chun ;
Jiang, Jian Dong ;
Tai, Li Wen ;
Zhang, Jin Li ;
Xu, En ;
Cheng, Yan ;
Heritier, Stephan ;
Morgenstern, Lewis B. ;
Chalmers, John .
LANCET NEUROLOGY, 2008, 7 (05) :391-399
[2]
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage [J].
Anderson, Craig S. ;
Heeley, Emma ;
Huang, Yining ;
Wang, Jiguang ;
Stapf, Christian ;
Delcourt, Candice ;
Lindley, Richard ;
Robinson, Thompson ;
Lavados, Pablo ;
Neal, Bruce ;
Hata, Jun ;
Arima, Hisatomi ;
Parsons, Mark ;
Li, Yuechun ;
Wang, Jinchao ;
Heritier, Stephane ;
Li, Qiang ;
Woodward, Mark ;
Simes, R. John ;
Davis, Stephen M. ;
Chalmers, John .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (25) :2355-2365
[3]
[Anonymous], 2015, STROKE
[4]
Optimal achieved blood pressure in acute intracerebral hemorrhage INTERACT2 [J].
Arima, Hisatomi ;
Heeley, Emma ;
Delcourt, Candice ;
Hirakawa, Yoichiro ;
Wang, Xia ;
Woodward, Mark ;
Robinson, Thompson ;
Stapf, Christian ;
Parsons, Mark ;
Lavados, Pablo M. ;
Huang, Yining ;
Wang, Jiguang ;
Chalmers, John ;
Anderson, Craig S. .
NEUROLOGY, 2015, 84 (05) :464-471
[5]
Complications of intracerebral haemorrhage [J].
Balami, Joyce S. ;
Buchan, Alastair M. .
LANCET NEUROLOGY, 2012, 11 (01) :101-118
[6]
Acute Blood Pressure Management in Intracerebral Hemorrhage Equipoise Resists an Attack [J].
Butcher, Kenneth ;
Selim, Magdy .
STROKE, 2016, 47 (12) :3065-3066
[7]
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial [J].
Butcher, Kenneth S. ;
Jeerakathil, Thomas ;
Hill, Michael ;
Demchuk, Andrew M. ;
Dowlatshahi, Dariush ;
Coutts, Shelagh B. ;
Gould, Bronwen ;
McCourt, Rebecca ;
Asdaghi, Negar ;
Findlay, J. Max ;
Emery, Derek ;
Shuaib, Ashfaq .
STROKE, 2013, 44 (03) :620-626
[8]
Journal Club: Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage [J].
Charidimou, Andreas ;
Morotti, Andrea ;
Valenti, Raffaella ;
Giese, Anne-Katrin ;
Boulouis, Gregoire ;
Pasi, Marco ;
Roongpiboonsopit, Duangnapa ;
Lauer, Arne ;
Xiong, Li ;
Van Harten, Thijs Wijnzen ;
Karadeli, Hasan ;
Fotiadis, Panagiotis ;
Jessel, Michael James ;
Viswanathan, Anand .
NEUROLOGY, 2016, 86 (20) :E206-E209
[9]
METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]
Defining hematoma expansion in intracerebral hemorrhage Relationship with patient outcomes [J].
Dowlatshahi, D. ;
Demchuk, A. M. ;
Flaherty, M. L. ;
Ali, M. ;
Lyden, P. L. ;
Smith, E. E. .
NEUROLOGY, 2011, 76 (14) :1238-1244